In multiple myeloma, Cohen et al showed that a higher CD4:CD8 T cell ratio in the leukapheresis product was associated with greater CAR-T cell expansion in the patient and with a greater therapeutic response [33]. The gene discussed is CD8A; the disease is AL amyloidosis.